Aurora Cannabis Inc. (TSE:ACB) Given Average Recommendation of “Moderate Buy” by Analysts

Aurora Cannabis Inc. (TSE:ACB) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and two have issued a strong buy rating on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is C$7.11.

Several research firms recently issued reports on ACB. ATB Capital decreased their target price on shares of Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday, December 17th. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th. Finally, Atb Cap Markets raised shares of Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th.

Aurora Cannabis Stock Down 1.4 %

Shares of TSE:ACB opened at C$9.06 on Friday. Aurora Cannabis has a 12-month low of C$3.84 and a 12-month high of C$12.85. The stock’s 50-day moving average price is C$6.30 and its two-hundred day moving average price is C$7.20. The company has a current ratio of 3.76, a quick ratio of 2.48 and a debt-to-equity ratio of 16.95. The firm has a market cap of C$495.22 million, a price-to-earnings ratio of -14.38 and a beta of 2.71.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.